Literature DB >> 9395018

Eosinophil expression of transforming growth factor-beta and its receptors in nasal polyposis: role of the cytokines in this disease process.

R J Eisma1, J S Allen, D Lafreniere, G Leonard, D L Kreutzer.   

Abstract

PURPOSE: Nasal polyposis (NP) is characterized by an increase in inflammatory processes including fibrosis. Because transforming growth factor beta (TGF-beta) has been proven to induce fibrosis, we hypothesize that TGF-beta and its receptors are present in NP and influence polyp development.
MATERIALS AND METHODS: To test this hypothesis, we evaluated distribution (immunohistochemistry) of TGF-beta isoforms (TGF-beta 1, TGF-beta 2, and TGF-beta 3) and its receptors [(TGF-beta(RI) & TGF-beta(RII)] in NP from 36 NP patients and in five normal sinus tissue specimens obtained from septoplasty/inferior turbinectomy. Tissue levels of TGF-beta 1 and TGF-beta 2 levels were determined by enzyme-linked immunosorbent assay (ELISA) and protein content was determined by Bio Rad assay (Bio Rad, Richmond, CA). All tissue levels of TGF-beta were normalized and expressed as pg of TGF-beta per mg of total protein (pg/mg TP).
RESULTS: Immunohistochemical studies showed eosinophils as the major cells positively staining for TGF-beta 1, TGF-beta 2, TGF-beta 3, TGF-beta(RI), and TGF-beta. In fibrotic sections, increased staining of eosinophils, fibroblast, and mononuclear cells was found for all three isoforms and both receptors. Evaluation of tissue levels indicated mean levels of TGF-beta 1 in the NP were 11.64 +/- 22.12 pg/mg TP versus normal control mean 44.36 +/- 22.12 pg/mg TP.TGF-beta 2 mean levels were 11.46 +/- 23.73 pg/mg TP versus normal control mean of 2.03 +/- 1.13 pg/mg TP. NP showed decreased expression of TGF-beta 1 and enhanced expression of TGF-beta 2 isoforms with presence of their receptors. Higher levels of TGF-beta 2 correlated with an increase in previous polypectomies perhaps indicative of severity of disease (P < or = .0001).
CONCLUSION: Our studies show the presence of the TGF-beta isoforms and receptors in NP tissue. The results support our hypothesis that the eosinophil continues to be a pivotal inflammatory cell in NP, a differential regulation may govern the activity of TGF-beta in NP, and hence, the TGF-beta family of cytokines and receptors likely play a key role in controlling NP formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395018     DOI: 10.1016/s0196-0709(97)90062-4

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  5 in total

1.  Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice.

Authors:  M P Macias; L A Fitzpatrick; I Brenneise; M P McGarry; J J Lee; N A Lee
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).

Authors:  F Levi-Schaffer; E Garbuzenko; A Rubin; R Reich; D Pickholz; P Gillery; H Emonard; A Nagler; F A Maquart
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

3.  Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation.

Authors:  S Ali; J Kaur; K D Patel
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components.

Authors:  Stephen R Reeves; Tessa Kolstad; Tin-Yu Lien; Molly Elliott; Steven F Ziegler; Thomas N Wight; Jason S Debley
Journal:  J Allergy Clin Immunol       Date:  2014-05-27       Impact factor: 10.793

5.  Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-β1 as compared with healthy nasal mucosa.

Authors:  Leonardo Balsalobre; Rogério Pezato; Claudina Perez-Novo; Maria Teresa S Alves; Rodrigo P Santos; Claus Bachert; Luc L M Weckx
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.